Paul Hastings Advised Keensight Capital in the Acquisition of Inke
June 07, 2023
Paul Hastings (Europe) LLP advised Keensight Capital in connection with the acquisition of Inke, a specialized inhalation active pharmaceutical ingredients (APIs) developer and manufacturer, previously owned by the Neuraxpharm Group.
More details on the transactions can be found here.
About Paul Hastings
With widely recognized elite teams in finance, mergers & acquisitions, private equity, restructuring and special situations, litigation, employment, and real estate, Paul Hastings is a premier law firm providing intellectual capital and superior execution globally to the world’s leading investment banks, asset managers, and corporations.